Mark Herring Associates, Inc.

CAGE Code: 3ETV5

NCAGE Code: 3ETV5

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 858846355

Summary

Mark Herring Associates, Inc. is an Active Commercial Supplier with the Cage Code 3ETV5 and is tracked by Dun & Bradstreet under DUNS Number 858846355..

Address

2150 Diamond Rock Hill Rd
Malvern PA 19355-9528
United States

Points of Contact

No Points of Contact...

Related Information

Associated CAGE Codes People who viewed this 'CAGE Code' also viewed...

CAGE Code FAQ Frequently Asked Questions (FAQ) for CAGE 3ETV5

What is CAGE Code 3ETV5?
3ETV5 is the unique identifier used by NATO Organizations to reference the physical entity known as Mark Herring Associates, Inc. located at 2150 Diamond Rock Hill Rd, Malvern PA 19355-9528, United States.
Who is CAGE Code 3ETV5?
3ETV5 refers to Mark Herring Associates, Inc. located at 2150 Diamond Rock Hill Rd, Malvern PA 19355-9528, United States.
Where is CAGE Code 3ETV5 Located?
CAGE Code 3ETV5 is located in Malvern, PA, USA.

Contracting History for CAGE 3ETV5 Contracting History for CAGE 3ETV5 Most Recent 25 Records

75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
3 Dec 2020
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$727,875.16
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
19 Dec 2021
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$727,875.16
75F40119C10118
Eo 14042 This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substa
29 Nov 2021
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$727,875.16
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
24 Sep 2019
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$595,345.32
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
2 Mar 2023
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$595,345.32
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
13 Aug 2020
Fda Office Of Acq&Grant Svcs
Department Of Health And Human Services (Hhs)
$727,875.16
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
14 Jan 2022
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$727,875.16
75F40119C10118
This Project Will Be Divided Into Phase One And Phase Two. Phase One Will Involve Collecting, Analyzing, Interpreting And Reporting Qualitative Data From ~140 Persons Who Have Used Prescription Opioids And At Least One Of Four Other Substances. Pha
11 Feb 2022
Fda Office Of Acq Grant Svcs
Department Of Health And Human Services (Hhs)
$654,275.16